「#Finance & Performance」Contents List
-
IR
Difference Between FY23/3 Q3 Earnings Forecast and Actual Results & Revision of Full-Year Earnings Forecast
IRDifference Between FY23/3 Q3 Earnings Forecast and Actual Results & Revision of Full-Year Earnings Forecast
-
IR
FY23/3 Q3 FX Loss, Extraordinary Gain and Loss, and Impairment Loss
IRFY23/3 Q3 FX Loss, Extraordinary Gain and Loss, and Impairment Loss
-
IR
Conversion of Class B and Class D Preferred Shares into Common Shares & New Controlling Shareholder
IRConversion of Class B and Class D Preferred Shares into Common Shares & New Controlling Shareholder
-
IR
Completion of Chinese Subsidiary Sale & Recording of Extraordinary Gain and Loss
IRCompletion of Chinese Subsidiary Sale & Recording of Extraordinary Gain and Loss
-
IR
INCJ Loan Extension & Ichigo Loan Repayment and New Loan
IRINCJ Loan Extension & Ichigo Loan Repayment and New Loan
-
IR
FY23/3 H1 Earnings Results
IRFY23/3 H1 Earnings Results
-
IR
Difference Between FY23/3 Q2 Earnings Forecast and Actual Results & Downward Revision of Full-Year Earnings Forecast
IRDifference Between FY23/3 Q2 Earnings Forecast and Actual Results & Downward Revision of Full-Year Earnings Forecast
-
IR
Foreign Exchange Gain
IRForeign Exchange Gain
-
IR
Signing of Share Purchase Agreement for Chinese Subsidiary Sale
IRSigning of Share Purchase Agreement for Chinese Subsidiary Sale
-
IR
FY23/3 Q1 Earnings Results
IRFY23/3 Q1 Earnings Results
-
IR
Difference Between FY23/3 Q1 Earnings Forecast and Actual Results (Sales Below Forecast, Earnings Above Forecast)
IRDifference Between FY23/3 Q1 Earnings Forecast and Actual Results (Sales Below Forecast, Earnings Above Forecast)
-
IR
Extraordinary Gain on Chinese Receivables (Disclosure Update), Foreign Exchange Gain, and Impairment Loss
IRExtraordinary Gain on Chinese Receivables (Disclosure Update), Foreign Exchange Gain, and Impairment Loss
-
IR
INCJ Loan Extension
IRINCJ Loan Extension
-
IR
(Disclosure Update) Extraordinary Gain on Chinese Receivables
IR(Disclosure Update) Extraordinary Gain on Chinese Receivables
-
IR
Difference Between FY22/3 Earnings Forecast and Actual Results & Recording of Extraordinary Loss (Impairment)
IRDifference Between FY22/3 Earnings Forecast and Actual Results & Recording of Extraordinary Loss (Impairment)
-
IR
FY22/3 Earnings Results
IRFY22/3 Earnings Results
-
IR
Extraordinary Gain on Chinese Receivables
IRExtraordinary Gain on Chinese Receivables
-
IR
Renewal of Patent Cross License Agreement with Innolux Corporation
IRRenewal of Patent Cross License Agreement with Innolux Corporation
-
IR
Completion of Exercise of 12th Series Stock Acquisition Rights
IRCompletion of Exercise of 12th Series Stock Acquisition Rights
-
IR
(Disclosure Update) Holding of Extraordinary Shareholders Meeting and Fixing of Record Date, Capital Reduction, and Surplus Appropriation
IR(Disclosure Update) Holding of Extraordinary Shareholders Meeting and Fixing of Record Date, Capital Reduction, and Surplus Appropriation